Shuai Shao

Immunogenicity and safety of NVSI-06-07 as a heterologous booster after priming with BBIBP-CorV: a phase 2 trial

Guizhen Wu, Jin Zhang, W. Lei, 2022, Signal Transduction and Targeted Therapy.

A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants

Weijin Huang, Zhaofeng Liu, Jin Zhang, 2022, bioRxiv.

Safety and immunogenicity of a hybrid-type vaccine booster in BBIBP-CorV recipients in a randomized phase 2 trial

Guizhen Wu, Jin Zhang, W. Lei, 2022, Nature Communications.

Safety and immunogenicity of a mosaic vaccine booster against Omicron and other SARS-CoV-2 variants: a randomized phase 2 trial

Guizhen Wu, Zhixin Ma, Shi Chen, 2023, Signal Transduction and Targeted Therapy.

Retracted: Exploring key genes and pathways underlying metastasis endometrial cancer based on gene expression microarray

Xinhui Sun, Na Liu, Hui Wang, 2018 .

miR-199a-5p stimulates ovarian granulosa cell apoptosis in polycystic ovary syndrome.

W. Shao, Na Liu, Hui Wang, 2020, Journal of molecular endocrinology.

Socioeconomic drivers and mitigating strategies of volatile organic compounds emissions in China's industrial sector

Hong Wang, Meiting Fan, Xiaoqian Song, 2023, Environmental Impact Assessment Review.